Abstract
The risk of systemic embolisation in patients with prosthetic heart valves who are receiving anticoagulation therapy is 0.5 to 1.7% per patient year and most cases present with cerebrovascular events. Here we report the case of a 42-year-old woman who was uneventfully treated with a low dose, prolonged infusion of tissue plasminogen activator because of non-obstructive prosthetic mitral valve thrombosis. It presented as coronary embolism and resulted in acute ST-elevation inferior myocardial infarction.
MeSH terms
-
Adult
-
Coronary Angiography
-
Coronary Thrombosis / chemically induced
-
Coronary Thrombosis / diagnosis*
-
Coronary Thrombosis / physiopathology
-
Drug Dosage Calculations
-
Echocardiography, Transesophageal
-
Electrocardiography
-
Female
-
Heart Valve Prosthesis Implantation*
-
Humans
-
Mitral Valve / diagnostic imaging
-
Mitral Valve / surgery
-
Mitral Valve Annuloplasty*
-
Myocardial Infarction / chemically induced
-
Myocardial Infarction / diagnosis*
-
Myocardial Infarction / physiopathology
-
Postoperative Complications / diagnosis*
-
Postoperative Complications / physiopathology
-
Tissue Plasminogen Activator / administration & dosage
-
Tissue Plasminogen Activator / adverse effects*
Substances
-
Tissue Plasminogen Activator